Monkeypox concept is the recent attention to a higher degree of popularity of the track, but most of the shareholders friends do not understand the monkeypox concept stock which, today financial Jun for the shareholders friends combed out the real monkeypox concept plate leading stocks list for your reference.
AntuBio (603658)(603658)
Zhengzhou Antu Bioengineering Co., Ltd. specializes in the research and development of in vitro diagnostic reagents and instrumentation, manufacturing, integration and services, the products cover the field of immunity, microbiology, biochemistry and other testing, but also in the field of molecular testing and other areas of active layout, can provide a comprehensive product solutions and medical laboratory. We are able to provide comprehensive product solutions and overall services for medical laboratories. The company's products are classified according to the detection method or application field, and are mainly divided into the following categories: immunological diagnostic reagents, microbiological detection reagents, biochemical detection reagents, molecular detection reagents, immunological, microbiological, molecular, clinical testing and other auxiliary equipment.
New Industry (300832)
Shenzhen New Industry Biomedical Engineering Co., Ltd.'s main business is the research and development of in vitro diagnostic products, production, sales and service, and it is the domestic leader in this field. The company's products are mainly used to provide diagnostic information for disease prevention, diagnosis, treatment monitoring, prognosis observation, health status evaluation and hereditary disease prediction. NIB is the first company in China to adopt the most advanced "nano-immunomagnetic beads" as the key separation material of the system, the first company in China to adopt the most advanced "synthetic small-molecule organic compounds" as the luminescent markers instead of traditional enzymes, and the first company in China to adopt the most advanced "synthetic small-molecule organic compounds" as the luminescent markers in the field. The first company in China to adopt the most advanced "synthetic small molecule organic compounds" in the field instead of traditional enzymes as luminescent markers, and the first company in China to apply direct chemiluminescence immunoassay technology and realize the mass production of fully automated chemiluminescence immunoassay instruments and supporting reagents.
Pumen Technology (688389)
Shenzhen Pumen Technology Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and service of medical devices. The Company's products mainly include multi-functional debridement instrument, photon therapy instrument, high-frequency vibration phlegm expectorator, air pressure wave therapy system, infrared therapy instrument, pulsed magnetic therapy instrument, intermediate-frequency interferential electrotherapy instrument, and shock wave therapy instrument. The company won the first prize of 2015 National Science and Technology Progress Award issued by the State Council, and is the first enterprise in the domestic medical device industry to win the first prize of National Science and Technology Progress Award.
Runda Medical (603108)(603108)
Shanghai Runda Medical Technology Co. Ltd.'s main business is the commercial service segment (IVD agent distribution business, intensive business/regional testing center business, third-party laboratory business) and the industrial segment (IVD product R&D and production business, the (IVD products R&D and production business, medical information technology business). Its main products include reagents and other consumables, instruments, software development and services.
Fosun Pharma (600196)(600196)
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. has main businesses of pharmaceuticals, medical devices and medical diagnostics, and healthcare services. The main products are core products in the field of treatment of cardiovascular system diseases, core products in the field of treatment of central nervous system diseases, core products in the field of treatment of blood system diseases, core products in the field of treatment of metabolic and digestive diseases, core products in the field of treatment of anti-infective diseases, core products in the field of treatment of antineoplastic diseases, core products in the field of APIs and intermediates. According to the 2018 list of the top 100 enterprises in China's pharmaceutical industry issued by the China Pharmaceutical (600056) Industry Information Center of the Ministry of Industry and Information Technology of the People's Republic of China*** and the State of China, the Group was ranked No. 7; according to the IQVIA statistics, in 2019, the Group ranked No. 10 in the country in terms of sales revenue from the hospital-use prescription drugs manufactured by the Group.As one of the largest enterprises in the world in the production, research and development, and manufacture of anti-malarials, the Group has become a member of the Global Fund, United Nations Children's Fund, World Health Organization and drug procurement centers in African countries...
Zhijiang Bio(688317)
Shanghai Zhijiang Bio-Technology Co. Ltd.'s main business is the research and development, production and sales of molecular diagnostic reagents and instrumentation. The company provides customers with high-quality products and one-stop technical services in the field of public health and safety and clinical diagnosis, and is committed to contributing to the cause of health care. The company's main products are molecular diagnostic reagents and instrumentation, and it is one of the enterprises with the most complete range of molecular diagnostic products for infectious diseases in China, and has developed more than 400 products covering most of the national statutory infectious diseases, which are widely used in the fields of public health and safety emergencies, clinical diagnostics, entry-exit inspection and quarantine, and food safety, and are exported to many countries and regions all over the world. The company has won the 'Second Prize of National Technology Invention Award', 'National Torch Plan Industrialization Demonstration Project Certificate' and many other honors and awards.
Huaren Pharmaceutical (300110)(300110)
The main business of Huaren Pharmaceutical Co., Ltd. is to engage in I.V. fluids (including non-PVC soft pouch, upright soft pouch, plastic vials, and glass vials of I.V. fluids), peritoneal dialysis fluids, respiratory drugs, and drugs in the field of spermatic anesthesia as well as raw material drugs, and ancillary medical package materials, Medical devices, health products research and development, production and sales. The main products of the company are basic infusion, therapeutic infusion and peritoneal dialysis fluid. The company is the designated infusion manufacturer for emergency reserve in Shandong Province, and has been listed in "China's Top 100 Pharmaceutical Industry" and "China's Top 100 Chemical Pharmaceutical Enterprises" for many times, and its peritoneal dialysis solution products have been successfully selected as the demonstration and promotion project of the Ministry of Health and the "Twelfth Five-Year Plan" project of the Ministry of Health. "Peritoneal dialysis products have been successfully selected for the demonstration and promotion project of Peritoneal Dialysis of the Ministry of Health of China and the National Science and Technology Support Program of the 12th Five-Year Plan.
Enhua Pharmaceuticals (002262)(002262)
Jiangsu Enhua Pharmaceuticals Co., Ltd.'s main business is the production, research and development and sales of pharmaceuticals, and pharmaceutical sales include sales of the company's production of pharmaceutical preparations, and pharmaceutical wholesale and retail business. The company is mainly engaged in the research and development of central nervous system drugs and cardiovascular drugs. The company is a national designated production base for narcotic and psychotropic drugs, and is an important manufacturer and seller of central nervous system drugs in China, as well as the only domestic pharmaceutical enterprise focusing on the research, development and production of central nervous system drugs.
Corfu Medical (301087)
Corfu Medical Technology Co., Ltd. is a leading large-scale, comprehensive home medical equipment enterprise, specializing in the research and development, production, sales and service of home medical equipment. The company's main products include blood pressure monitors, blood glucose meters, infrared thermometers, wheelchairs, nursing beds, walkers, hearing aids, non-invasive ventilators, oxygen concentrators, nebulizers moxibustion series, massage and traction class, health protection consumables and so on. The company has won the honors of "Changsha Intelligent Manufacturing Pilot Enterprise", "Hunan High-tech Enterprise", "Changsha Enterprise Technology Center" and so on in terms of technological process. The self-developed hearing aids, audiometers, sphygmomanometers, nebulizers and other products are at the leading level in China.
Mecan Bio(300439)(300439)
Mecan BioScience and Technology Co., Ltd. is mainly engaged in the research and development, production and sales of in vitro diagnostic products and the provision of third-party medical diagnostic services. The company's own products cover biochemistry, chemiluminescence, blood cells, POCT, molecular diagnostics, urine, mass spectrometry, VAP lipids typing and other fields, has become the domestic in vitro diagnostic production enterprises in the most abundant products one of the enterprises, and at the same time with the formation of international brands of strategic cooperation, to better meet the needs of customers at all levels of health care institutions, medical examination centers and independent medical laboratories.